Conclusion
Autoaggressive T cells specific for the PNS myelin P2 protein play a central role in the initiation of EAN in the Lewis rat, although there is as yet no direct experimental evidence that the T cells can themselves mediate demyelination in vivo. However, the striking similarities in the pathogenesis of EAN and the Guillain-Barré syndrome suggest that T cell mediated EAN provides an excellent model to study the immunological mechanisms of inflammation and demyelination that are relevant to human PNS disease.
Similar content being viewed by others
References
B. H. Waksman and R. D. Adams,Allergic neuritis: An experimental disease of rabbits induced by injection of peripheral nervous tissue and adjuvants. J. Exp. Med.102, 213–234 (1955).
B. H. Waksman and R. D. Adams,A comparative study of experimental allergic neuritis in rabbit, guinea pig and mouse. J. Neuropath. Exp. Neurol.15, 293–314 (1956).
P. W. Lampert,Mechanisms of demyelination in experimental allergic neuritis.—Electron microscopic studies. Lab. Invest.20, 127–138 (1969).
R. H. M. Ballin and P. K. Thomas,Electron-microscopic observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination., J. Neurol. Sci.8, 1–18 (1969).
B. G. W. Arnason, Inflammatory polyradiculoneuritis. In:Peripheral Neuropathy, Vol. 2 (Eds P. J. Dyck, P. K. Thomas and E. H. Lambert). Saunders, Philadelphia 1975.
J. W. Prineas,Pathology of the Guillain-Barré Syndrome. Ann. Neurol. [Suppl.]9, 6–19 (1981).
A. Iqbal, J. J. F. Oger and B. G. W. Arnason,Cell mediated immunity in idiopathic polyneuritis. Ann. Neurol.9, 65–69 (1981).
B. Zweiman, A. Rostami, R. P. Lisak, A. R. Moskovitz and D. E. Pleasure,Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Neurology33, 234–237 (1983).
C. Linington, S. Izumo, M. Suzuki, K. Uyemura, R. Meyermann and H. Wekerle,A permanent rat T-cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J. Immunol.133, 1946–1951 (1984).
S. Izumo, C. Linington, H. Wekerle and R. Meyermann,A morphological study on experimental allergic neuritis mediated by a T-cell line specific for bovine P2 protein in the Lewos rat. Lab. Invest.53, 209–218 (1985).
K. Heininger, G. Stoll, C. Linington, K. V. Toyka and H. Wekerle,Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines. Ann. Neurol.19, 44–49 (1986).
H. Wekerle, M. Schwab, C. Linington and R. Meyermann,Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Submitted.
M. E. Smith, L. S. Forno and W. W. Hofmann,Experimental neuritis in the Lewis rat. J. Neuropathol. Exp. Neurol.38, 377–391 (1979).
M. Kablubowski and R. A. C. Hughes,Identification of the neuritogen responsible for EAN, Nature277, 140–141 (1979).
M. Kablubowski, R. A. C. Hughes and N. A. Gregson,Experimental allergic neuritis in the Lewis rat: characterisation of the activity of peripheral myelin and its major basic protein, P2. Brain Res.184, 439–454 (1980).
K. Saida, T. Saida, D. E. Pleasure and H. Nishitani,P2 protein induced experimental allergic neuritis—an ultrastructural study. J. Neurol. Sci.62, 77–93 (1983).
D. J. Mikek, H. O. Sarvas, S. Greenfield and S. W. Brostoff,An immunological characterisation of the basic proteins of rodent sciatic nerve myelin. Brain Res.208, 387–396 (1981).
R. A. C. Hughes, M. Kablubowski, I. A. Gray and S. Leibowitz,Immune responses in experimental allergic neuritis. J. Neurol. Neurosurg. Psych.44, 565–569 (1981).
I. Szymanska, J. Ramvani and E. H. Eylar,The passive transfer of severe experimental allergic neuritis in the Lewis rat with lymphoid cells preincubated with P2 protein. Cell Immunol.82, 422–425 (1983).
A. Ben Nun, H. Wekerle and I. R. Cohen,The rapid isolation of antigen specific T lymphocyte lines capable of mediating experimental autoimmune encephalomyelitis. Eur. J. Immunol.114, 1537–1540 (1981).
C. Linington, A. Mann, S. Izumo, K. Uyemura, R. Meyermann and H. Wekerle,Induction of experimental allergic neuritis in the BN rat: P2 protein specific T cells overcome resistance to disease. Submitted.
P. M. Hoffman, J. M. Powers, M. J. Weise and S. W. Brostoff,Experimental allergic neuritis. I. Rat strain differences in the response to bovine myelin antigens. Brain Res.195, 355–362 (1980).
K. Uyemura, M. Suzuki, K. Kitamura, K. Horie, Y. Ogawa, H. Matsuyama, S. Nozaki and I. Muramatsu,Neuritogenic determinant of bovine P2 protein in peripheral nerve myelin. J. Neurochem.39, 895–898 (1982).
R. M. Williams and M. J. Moore,Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility complex in the rat. J. Exp. Med.138, 775–783 (1973).
Y. Olsson,Studies on vascular permeability in peripheral nerves. IV. Distribution of intravenously injected protein tracers in the peripheral nervous system of various species. Acta Neuropathol.10, 26–37 (1971).
E. R. Unanue, D. I. Beller, C. Y. Lu and P. M. Allen,Antigen presentation: Comments on its regulation and mechanisms. J. Immunol.132, 1–5 (1984).
B. D. Trapp, M. Dubois-Dalcq and R. H. Quarles,Ultrastructural localisation of P2 protein in actively myelinating Schwann cells. J. Neurochem.43, 944–948 (1984).
H. Wekerle, C. Linington, H. Lassmann and R. Meyermann,Cellular immune reactivity within the central nervous system. TINS.9, 271–277 (1986).
R. Meyermann, P. W. Lampert, H. Korr and H. Wekerle,T line mediated EAE. A morphological study of the developing lesion. (Abstract). J. Neuropathol. Exp. Neurol.44, 320–321 (1985).
H. Hirschberg, O. J. Bergh and E. Thorsby,Antigen presenting properties of human vascular endothelial cells. J. Exp. Med.152, 249–255 (1980).
G. Nunez, E. J. Ball and P. Stastny,Accessory function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. J. Immunol.131, 666–673 (1983).
T. Olsson, R. Holmdahl, L. Klareskog and U. Forsum,Ia expressing cells and T-lymphocytes of different subsets during experimental allergic neuritis in Lewis rats.Scand. J. Immunol. 18, 339–343 (1983).
T. Olsson, R. Holmdahl, L. Klareskog, U. Forsum and K. Kristensson,Dynamics of Ia-expressing cells and T-lymphocytes of different subsets during experimental allergic neuritis in Lewis rats. J. Neurol. Sci.66, 141–149 (1984).
R. I. Craggs and H. de F. Webster,Ia antigens in the normal rat nervous system and in lesions of experimental allergic encephalomyelitis. Acta Neuropathol.68, 263–272 (1985).
H. Lassmann, K. Vass, C. Brunner and H. Wisniewski,Peripheral nervous system lesions in experimental allergic encephalomyelitis. Acta Neuropathol.69, 193–204 (1986).
R. A. Sobel, B. W. Blanchette, A. K. Bhan and R. B. Colvin,The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J. Immunol.132, 2402–2407 (1984).
K. A. Brown and D. C. Dumonde, The immunopathological significance of leucocyte-endothelial interactions. InThe blood-brain barrier in health and disease (Eds A. J. Suckling, M. G. Rumsby and M. W. B. Bradbury). Ellis Horwood, Chichester, England 1986.
N. Savion, I. Vlodavsky and Z. Fuks,Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: Attachment, invasion and subsequent degradation of the subendothelial extracellular matrix. J. Cell. Physiol.118, 169–178 (1984).
R. P. Lisak, M. Hirayama, D. Kuchmy, A. Rosenzweig, S. U. Kim, D. E. Pleasure and D. H. Silverberg,Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene-associated antigen (Ia) on their surface. Brain Res.289, 285–292 (1983).
J. H. Meador-Woodruff, J. E. Yoshino, J. W. Bigbee, B. L. Lewis and G. Devries,Differential proliferation responses of cultured Schwann cells to axolemme and myelin-enriched fractions. J. Neurocytol.14, 619–628 (1985).
J. Winter, R. Mirsky and M. Kablubowski,Immunocytochemical study of the appearance of P2 in developing rat peripheral nerve: comparison with other myelin components. J. Neurocytol.11, 351–362 (1982).
J. N. Whitaker,The protein antigens of peripheral nerve myelin. Ann. Neurol. [Suppl]9, 421–444 (1981).
K. Saida, T. Saida, M. J. Brown, D. H. Silverberg and A. K. Asbury,Antiserum mediated demyelination in vivo. A sequential study using intraneural injection of experimental allergic neuritis serum. Lab. Invest.39, 449–462 (1978).
A. F. Hahn, J. J. Gilbert and T. E. Feasby,Passive transfer of demyelination by experimental allergic neuritis serum. Acta Neuropathol. (Berlin)49, 189–196 (1980).
T. Yonezawa, Y. Ishihara and H. Matsuyama,Studies on experimental allergic peripheral neuritis. I. Demyelinating patterns studied in vitro. J. Neuropath. Exp. Neurol.27, 453–463 (1968).
H. C. Agrawal, H. B. Clark, D. Agrawal, F. J. Seil and R. H. Quarles,Identification of antibodies in anti-CNS and anti-PNS myelin sera by immunoblot, characterisation by immunohistochemistry and their effect in tissue culture. Brain Res.307, 191–200 (1984).
K. Saida, T. Saida, M. J. Brown and D. H. Silverberg,In vivo demyelination induced by intraneural injection of antigalactocerebroside serum. A morphological study. Am. J. Pathol.95, 99–110 (1979).
W. M. Carroll, A. R. Jennings and F. L. Mastaglia,Experimental demyelinating optic neuropathy induced by intraneural injection of galactocerebroside antiserum. J. Neurol. Sci.65, 125–135 (1984).
T. Saida, K. Saida, S. Dorfman, D. H. Silverberg, A. J. Sumner, M. C. Manning, R. P. Lisak and M. J. Brown,Experimental allergic neuritis induced by sensitization with galactocerebroside. Science204, 1103–1106 (1979).
R. A. C. Hughes and H. C. Powell,Experimental allergic neuritis: Demyelination induced by P2 alone and non-specific enhancement by cerebroside. J. Neuropathol. Exp. Neurol.43, 154–161 (1984).
C. L. Koski, P. Vanguri and M. L. Shin,Activation of the alternative pathway of complement by human peripheral nerve myelin. J. Immunol.134, 1810–1814 (1985).
D. Sun and H. Wekerle,Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature320, 70–72 (1986).
D. W. Mason, R. P. Arthur, M. J. Dallman, J. R. Green, G. P. Spickett and M. L. Thomas,Functions of rat T cell subsets isolated by means of monoclonal antibodies. Immunol. Rev.74, 57–82 (1983).
B. G. W. Arnason and E. Chelmicka-Szorc,Passive transfer of EAN in Lewis rats by direct injection of sensitised lymphocytes into the sciatic nerve. Acta Neuropath. (Berlin)22, 1–6 (1972).
J. J. Gilbert, T. E. Feasby and A. F. Hahn,Intraneural injection of lymphocytes in experimental allergic neuritis. Acta Neuropathol. (Berlin)61, 61–64 (1983).
B. G. W. Arnason, G. F. Winkler and N. M. Hadler,Cell-mediated demyelination of peripheral nerve in culture. Lab. Invest.21, 1–10 (1969).
H. M. Wisniewski and B. R. Bloom,Primary demyelination as a non-specific consequence of a cell mediated immune response. J. Exp. Med.141, 346–359 (1975).
R. A. C. Hughes and H. C. Powell,Experimental allergic neuritis: Demyelination induced by P2 alone and non-specific enhancement by cerebroside. J. Neuropathol. Exp. Neurol.43, 154–161 (1984).
H. C. Powell, S. L. Brahney, R. R. Myers, M. Rodriguez and P. W. Lampert,Early changes in experimental allergic neuritis. Lab. Invest.48, 332–338 (1983).
M. Dal Canto, H. M. Wisniewski, A. B. Johnson, S. W. Brostoff and C. S. Raine,Vesicular disruption of myelin in autoimmune demyelination. J. Neurol. Sci.24, 313–319 (1975).
F. A. Tansey and C. F. Brosnan,Protection against experimental allergic neuritis with silica quartz dust. J. Neuroimmunol.3, 169–179 (1983).
R. I. Craggs, R. H. M. King and P. K. Thomas,The effect of suppression of macrophage activity on the development of experimental allergic neuritis. Acta Neuropathol.62, 316–323 (1984).
Y. Yarom, Y. Naparstek, V. Lev-Ram, J. Holoshitz, A. Ben-Nun and I. R. Cohen,Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin. Nature303, 246–247 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Linington, C., Wekerle, H. & Meyermann, R. T lymphocyte autoimmunity in peripheral nervous system autoimmune disease. Agents and Actions 19, 256–265 (1986). https://doi.org/10.1007/BF01971223
Issue Date:
DOI: https://doi.org/10.1007/BF01971223